← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2008Last known activity
Jul 1, 2020
Timeline
2000s
- Jun 1, 2008
Immetacyte— Founded
Drugs by trial phase (6 distinct, 2 trials)
Phase 2 (6 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT04389229Lead sponsorPhase 1/Phase 2Jul 1, 2020
- NCT00446836CollaboratorPhase 2Mar 1, 2005
Details
- Founded
- Manchester, GB Jun 1, 2008
- Last known activity
- Jul 1, 2020